Mirae Asset Global Investments’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Mirae Asset Global Investments’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-28,111	Closed	-$1.92M	–	2669
2022 Q3	$1.92M	Buy	28,111 +8,014	+40%	+$442K	0.01%	1155
2022 Q2	$642K	Buy	+20,097	New	+$588K	﹤0.01%	1635
2021 Q4	–	Sell	-8,630	Closed	-$220K	–	1804
2021 Q3	$220K	Buy	8,630 +441	+5%	+$13K	﹤0.01%	1668
2021 Q2	$287K	Buy	8,189 +21	+0.3%	+$820	﹤0.01%	1589
2021 Q1	$333K	Sell	8,168 -75	-0.9%	-$3.45K	﹤0.01%	1391
2020 Q4	$357K	Sell	8,243 -172	-2%	-$8.48K	﹤0.01%	1403
2020 Q3	$464K	Buy	8,415 +622	+8%	+$39.5K	﹤0.01%	1209
2020 Q2	$492K	Sell	7,793 -961	-11%	-$65.9K	﹤0.01%	1147
2020 Q1	$447K	Buy	+8,754	New	+$586K	﹤0.01%	1059
2018 Q3	–	Sell	-23,939	Closed	-$1.08M	–	1356
2018 Q2	$1.08M	Buy	+23,939	New	+$1.09M	0.01%	496
2017 Q4	–	Sell	-16,082	Closed	-$499K	–	722
2017 Q3	$499K	Buy	+16,082	New	+$452K	0.01%	532

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mirae Asset Global Investments's GBT Position: Q4 2022 in Review

Mirae Asset Global Investments sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 28,111 shares — an estimated $1.92M sold.

Mirae Asset Global Investments first reported a position in GBT in Q3 2017 and held it in 11 quarters. The position peaked at $1.92M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Mirae Asset Global Investments reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Mirae Asset Global Investments sold 28,111 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $1.92M.
Mirae Asset Global Investments first reported a position in Global Blood Therapeutics, Inc. in Q3 2017 and held it in 11 quarters.
Mirae Asset Global Investments's Global Blood Therapeutics, Inc. position peaked at $1.92M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Mirae Asset Global Investments's 13F filing for Q4 2022, filed 9 Feb 2023.